欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置 : 首页  /  Cell Cycle  /  Microtubule/Tubulin  /  Tubulysin M/微管蛋白抑制剂 M

CAS No.: 936691-46-2

Tubulysin M/微管蛋白抑制剂 M Catalog No. CSN20039

Synonyms: 微管蛋白抑制剂 M

Tubulysin M is a myxobacterial product that can function as an antiangiogenic agent in many in vitro assays with anti-microtubule, anti-mitotic, an apoptosis inducer, anticancer, anti-angiogenic, and antiproliferative activity.

规格 价格 促销价格 库存 数量
纯度 & 质量文件 批次:

靶点选择性

生物活性

  • 描述
  • 临床研究
  • NCT号适应症或疾病临床期招募状态预计完成时间地点
    NCT03011320Ovary CancerPhase 1Active, not recruitingAugust 1, 2018United States, North Carolina ... more >> Levine Cancer Institute-Concord/Clinical Trials Concord, North Carolina, United States, 28025 Canada, Ontario Ottawa Hospital Ottawa, Ontario, Canada, K1H 8L6 Collapse <<
    NCT02202447Prostate CancerPhase 1Active, not recruitingOctober 2018United States, Arizona ... more >> Scottsdale Healthcare Clinical Trials at the Virginia G. Piper Cancer Center Scottsdale, Arizona, United States, 85258 United States, Connecticut Yale Cancer Center New Haven, Connecticut, United States, 06520 United States, Louisiana Tulane Cancer Center New Orleans, Louisiana, United States, 70112 United States, Nevada Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89169 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10017 United States, Texas South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 Collapse <<

实验方案

技术信息

CAS号 936691-46-2 储存条件
分子式 C38H57N5O7S 运输 蓝冰
分子量 727.95 别名 微管蛋白抑制剂 M

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们